Dementia Alzheimer's type

• Open-label Extension of KarXT + KarX-EC for Agitation in Alzheimer’s Disease Pending
  2024-519994-20-00 5 "Agitation Associated with Alzheimer’s Disease"
• MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A MRI/TEP STUDY Pending
  2024-519995-20-00 10 "Maladie d' Alzheimer"
• CIRAANO: Multimodal exploration of theater actors, memory athletes, and patients with various memory pathologies: evaluation of mnesic strat … Pending
  2025-523264-21-00 10 "Semantic Variant Primary Progressive Aphasia"
• A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease Recruiting
  2025-520746-30-00 5 2025-11-18 "Mild to moderate Alzheimer’s Disease"
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated with Alzheimer’s Disease. Recruiting
  2025-520612-34-00 5 2025-11-28 "Agitation Associated with Alzheimer’s Disease"
• A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated with Alzheimer’s Disease. Recruiting
  2025-520613-31-00 5 2025-10-31 "Agitation Associated with Alzheimer’s Disease"
• A Phase 3 Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer’s Disease Recruiting
  2025-520747-32-00 5 2025-10-29 "Mild to moderate Alzheimer’s Disease"
• A study to assess the efficacy and safety of ITI-1284 in the treatment of Psychosis Associated with Alzheimer's Disease Recruiting
  2024-513035-25-00 4 2025-07-11 "Psychosis associated with Alzheimer’s Disease"
• A Phase 3, Parallel Group Study to Evaluate KarXT as a Treatment for Psychosis Associated with Alzheimer’s Disease Recruiting
  2024-516363-92-00 5 2025-04-08 "Psychosis Associated with Alzheimer’s Disease"
• This 52-week, open-label extension study is to evaluate the long-term safety and tolerability of ACP-204 in subjects with ADP. Recruiting
  2023-507351-29-00 5 2024-12-03 "Alzheimer's Disease Psychosis"
• A study to see how well KarXT is tolerated and how well tolerated it is when taken for long time in participants with psychosis associated w … Recruiting
  2023-504151-27-00 5 2024-05-09 "Psychosis associated with Alzheimer’s Disease"
• Research study to assess the potential of masupirdine in patients with agitation symptoms associated with memory loss Recruiting
  2024-513835-25-00 5 2022-10-27 "Agitation with Dementia of the Alzheimer's Type"
• The BioFINDER 2 study - improved diagnostics and increased understanding of the pathophysiology of cognitive disorders Recruiting
  2024-511842-38-00 4 2017-04-10 "Neurodegenerative disorders with Tau-pathology; including, b"
• A study to assess the efficacy and safety of ITI-1284 in the treatment of Agitation Associated with Alzheimer's Dementia Recruitment ended
  2024-514680-26-00 4 2025-07-17 "Agitation Associated with Alzheimer’s Dementia"
• ACP-204 in Adults with Alzheimer’s Disease Psychosis Recruitment ended
  2023-507325-42-00 4 2024-07-02 "Alzheimer Disease psychosis"
• A study to see how well KarXT works and how well tolerated it is in participants with psychosis associated with Alzheimer’s disease. Recruitment ended
  2023-504416-16-00 5 2024-04-11 "Psychosis Associated with Alzheimer’s Disease"
• Characterization of Immune Response in Participants from a Posdinemab Study Ended
  2024-514634-20-00 3 2025-02-25 "Early Alzheimer's disease"
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended
  2023-504991-31-00 5 2021-05-06 "Agitation in Patients With Dementia of the Alzheimer's Type"
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's … Ended
  2023-504990-19-00 5 2021-04-06 "Agitation in Patients With Dementia of the Alzheimer's Type"
• A Phase 2 Trial Evaluating the Effects of Thiethylperazine as diagnostic tool and therapeutic agent in Patients Diagnosed with an Early Stag … Ended
  2022-501137-23-00 4 "Newly diagnosed early-to-mild dementia due to Alzheimer's Di"

Showing 1–20 of 20 trials